Payment & Shipping Terms:
|Specification:||10iu/vial 10vials/kit 100iu/kit||Policy:||Reshipping Policy|
|Description:||White Lyophilized Powder||Function:||Muscle Gaining|
|Shipping:||EMS, HKEMS, DHL, FEDEX||Delivery:||5-7 Days|
oral human growth hormone,
legal human growth hormone
100iu Real Gensci Bodybuilding HGH Human Growth Hormone Somatropin
Somatropin dosing information:
Usual Adult Dose for Adult Human Growth Hormone Deficiency:
Weight Based Regimen:
Initial dose: Not more than 0.004 mg/kg subcutaneously once a day (or a total of 0.04 mg/kg per week in divided doses).
Maximum dose: 0.016 mg/kg once a day (0.08 mg/kg per week in divided doses)
Non-Weight Based Regimen:
Approximately 0.2 mg subcutaneously once a day (range: 0.15 to 0.3 mg once a day)
-The weekly dose should be divided over 6 or 7 days of subcutaneous injections.
-May increase dose (weight or non-weight based) at 4 to 8 week intervals, by increments of approximately 0.1 to 0.2 mg per day (not more than 0.004 mg/kg per day), based on clinical response and serum IGF-I concentrations.
-The dose should be decreased as necessary on the basis of adverse events and/or serum IGF-I concentrations above the age- and gender-specific normal range.
-Maintenance dosages vary considerably from person to person, and between male and female patients.
-Obese individuals are more likely to manifest adverse effects when treated with a weight-based regimen. -To reach the defined treatment goal, estrogen-replete women may need higher doses than men.
Uses: Replacement of endogenous growth hormone (GH) in adults with growth hormone deficiency (GHD) who meet either of the following two criteria:
-Adult Onset (AO): Patients who have GHD, either alone or associated with multiple hormone deficiencies (hypopituitarism), as a result of pituitary disease, hypothalamic disease, surgery, radiation therapy, or trauma; or
-Childhood Onset (CO): Patients who were GH deficient during childhood as a result of congenital, genetic, acquired, or idiopathic causes. Reevaluate patients treated for childhood GHD whose epiphyses are closed before continuing therapy at the reduced dose level recommended for adults.
-Confirmation of the diagnosis of adult GHD in both groups involves an appropriate growth hormone provocative test with two exceptions: (1) patients with multiple other pituitary hormone deficiencies due to organic disease; and (2) patients with congenital/genetic growth hormone deficiency.
Usual Adult Dose for Cachexia:
0.1 mg/kg subcutaneously once a day at bedtime
Under 35 kg/ 75 lbs: 0.1 mg/kg subcutaneously once a day at bedtime
35 to 45 kg/ 75 to 99 lbs: 4 mg subcutaneously once a day at bedtime
45 to 55 kg/ 99 to 121 lbs: 5 mg subcutaneously once a day at bedtime
Over 55 kg/ 121 lbs: 6 mg subcutaneously once a day at bedtime
Maximum dose: 6 mg once a day
-Most of the effect on work output and lean body mass were seen after 12 weeks of treatment.
-There are no data on safety or efficacy with use beyond 48 weeks.
-There are no data on safety or efficacy of intermittent treatment.
Use: Treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight, and improve physical endurance.
Usual Adult Dose for Short Bowel Syndrome:
Approximately 0.1 mg/kg subcutaneously once a day
Maximum dose: 8 mg once a day
Duration of therapy: 4 weeks
-Administration for more than 4 weeks has not been adequately studied.
-Use in conjunction with optimal management of Short Bowel Syndrome (SBS).
-Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, fluid, and micronutrient supplements, as needed.
-Specialized nutritional support may consist of a high carbohydrate, low-fat diet, adjusted for patient requirements and preferences.
-Nutritional supplements may be added at the discretion of the treating physician.
-Changes to concomitant medications should be avoided.
-Patients and physicians should monitor for adverse events.
Use: Treatment of Short Bowel Syndrome in patients receiving specialized nutritional support.
Usual Pediatric Dose for Pediatric Growth Hormone Deficiency:
Pediatric Growth Hormone Deficiency (GHD):
0.024 to 0.034 mg/kg subcutaneously once a day, 6 to 7 times a week
Prader-Willi syndrome (PWS):
Up to 0.24 mg/kg per week; divided over 6 or 7 days of subcutaneous injections
What other drugs will affect somatropin?
Tell your doctor about all your current medicines and any you start or stop using, especially:
birth control pills or hormone replacement therapy
insulin or oral diabetes medicine; or
steroid medicine (prednisone, dexamethasone, methylprednisolone, and others).
This list is not complete. Other drugs may interact with somatropin, including prescription and over-the-counter medicines
|HMG||75 IU/vial, 6vials/kit|
|hgh blue/yellow/green/black top||10IU/vial,10vials/kit|
|CJC-1295 without DAC||2mg/vial,10vials/kit|
|CJC-1295 without DAC||5mg/vial,10vials/kit|
|CJC-1295 without DAC||10mg/vial,10vials/kit|
|CJC-1295 with DAC||2mg/vial,10vials/kit|
|CJC-1295 with DAC||5mg/vial,10vials/kit|
|CJC-1295 with DAC||10mg/vial,10vials/kit|
|HGH Fragment 176-191||2mg/vial,10vials/kit|
|HGH Fragment 176-191||5mg/vial,10vials/kit|
|HGH Fragment 176-191||10mg/vial,10vials/kit|
Contact Person: sales